Mizuho raised the firm’s price target on Doximity (DOCS) to $62 from $60 and keeps a Neutral rating on the shares. The firm upped estimates post the earnings report citing revenue and margin strength.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
- Doximity price target lowered to $58 from $67 at Canaccord
- Doximity’s Earnings Call: Strong Growth and AI Focus
- Doximity price target lowered to $70 from $81 at Evercore ISI
- Balanced Outlook on Doximity: Strong Performance Meets Conservative Guidance
- Doximity Reports Strong Q2 Growth and AI Expansion